1. Home
  2. EBF vs IPSC Comparison

EBF vs IPSC Comparison

Compare EBF & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ennis Inc.

EBF

Ennis Inc.

HOLD

Current Price

$21.49

Market Cap

519.5M

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.43

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBF
IPSC
Founded
1909
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
519.5M
441.9M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
EBF
IPSC
Price
$21.49
$2.43
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.25
AVG Volume (30 Days)
160.1K
1.9M
Earning Date
04-20-2026
05-11-2026
Dividend Yield
4.85%
N/A
EPS Growth
7.79
91.30
EPS
0.39
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
$2.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$55.10
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$16.30
$0.44
52 Week High
$22.36
$2.97

Technical Indicators

Market Signals
Indicator
EBF
IPSC
Relative Strength Index (RSI) 57.03 56.52
Support Level $19.92 $2.13
Resistance Level $22.36 $2.45
Average True Range (ATR) 0.58 0.18
MACD 0.10 0.02
Stochastic Oscillator 77.72 68.00

Price Performance

Historical Comparison
EBF
IPSC

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others. The company's single reportable segment : Print derives its operating revenues from the manufacturing of mostly custom or semi-custom printed products sold mostly to independent distributors in the United States.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: